WHO ICTRP trial
To see the effect of combined injections and radiation therapy along with…
CTRI/2024/02/062372 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/02/062372 |
|---|---|
| Public title | To see the effect of combined injections and radiation therapy along with special injections called immunotherapy on the outcome of breast cancers which are hormone receptor negative |
| Scientific title | Evaluating the role of addition of low-dose nivolumab and concurrent radiation in patients with triple negative breast cancer receiving neoadjuvant chemotherapy (NACT): a phase 2 Randomized controlled trial (RCT). - Nil |
| Primary sponsor | Cancer Institute |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: C509- Malignant neoplasm of breast of unspecified site |
| Interventions | Intervention1: Neoadjuvant concurrent chemoradiation: 4 cycles Paclitaxel and carboplatin with concurrent radiation to breast and nodal areas followed by 4 cycles Adriamycin and cyclophosphamide Intervention2: Neoadjuvant chemotherapy with… |
| Registration date | Jul 2, 2024 |
| Target size | 128 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: